Posts by: Jose Marques Lopes, PhD

News

The U.S. Food and Drug Administration has accepted for review AstraZeneca‘s request to use acalabrutinib — a highly selective BTK inhibitor — to treat relapsed or refractory mantle cell lymphoma (MCL) ... Read more

April 27, 2017

Scientists Use Case Studies to Seek Clues About Link Between Lupus and Lymphoma

News

Chicago researchers looked at three people who developed lymphoma at different stages of their lupus disease to try to find clues on the association between the conditions. Their study, ... Read more

April 11, 2017

Alexo Starts Phase 1 Clinical Trial of ALX148 for Solid Tumors and Lymphoma

News

Alexo Therapeutics has begun dosing patients in a Phase 1 clinical trial designed to evaluate the characteristics in the body and the safety of the CD47 inhibitor ALX148 in patients with advanced solid tumors ... Read more

March 9, 2017

Gluten Response in Celiac Patients Could Lead to Lethal Lymphoma, Study Suggests

News

Production of pro-inflammatory cytokines by the body’s immune system triggered by a reaction to gluten in celiac patients may lead to a rare and lethal type of lymphoma, a Dutch study ... Read more